tradingkey.logo

Sophia Genetics SA

SOPH
4.370USD
-0.370-7.81%
收盘 11/07, 16:00美东报价延迟15分钟
296.49M总市值
亏损市盈率 TTM

Sophia Genetics SA

4.370
-0.370-7.81%

关于 Sophia Genetics SA 公司

Sophia Genetics SA 是一家总部位于瑞士的公司,从事软件出版行业。该公司提供基于云的软件即服务平台 - SOPHiA DDM,这是一个数据驱动的医疗平台,可以从不同的复杂数据集中获取见解,以改善诊断、治疗和药物开发。该公司在瑞士、法国和英国设有办事处,业务遍布全球。

Sophia Genetics SA简介

公司代码SOPH
公司名称Sophia Genetics SA
上市日期Jul 23, 2021
CEODr. Jurgi Camblong, Ph.D.
员工数量423
证券类型Ordinary Share
年结日Jul 23
公司地址La Piece 12
城市ROLLE
上市交易所NASDAQ Global Select Consolidated
国家Switzerland
邮编1180
电话41216941060
网址https://www.sophiagenetics.com/
公司代码SOPH
上市日期Jul 23, 2021
CEODr. Jurgi Camblong, Ph.D.

Sophia Genetics SA公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
60.38K
+51.32%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer and Chief Product Officer
Chief Medical Officer and Chief Product Officer
39.60K
-5.14%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jean-Michel Cossiery, Ph.D.
Mr. Jean-Michel Cossiery, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暂无数据
地区USD
名称
营收
占比
Rest of EMEA
5.78M
31.53%
Italy
2.78M
15.19%
France
2.72M
14.82%
United States
2.66M
14.52%
Spain
1.63M
8.90%
其他
2.75M
15.04%
业务
地区
暂无数据

股东统计

更新时间: 11月4日 周二
更新时间: 11月4日 周二
持股股东
股东类型
持股股东
持股股东
占比
Alychlo NV
10.31%
Generation Investment Management LLP
10.01%
aMoon Fund
8.12%
Akre Capital Management, LLC
5.48%
Balderton Capital (UK) LLP
4.96%
其他
61.13%
持股股东
持股股东
占比
Alychlo NV
10.31%
Generation Investment Management LLP
10.01%
aMoon Fund
8.12%
Akre Capital Management, LLC
5.48%
Balderton Capital (UK) LLP
4.96%
其他
61.13%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
16.14%
Venture Capital
13.13%
Family Office
10.40%
Investment Advisor
8.46%
Individual Investor
6.46%
Hedge Fund
1.43%
Bank and Trust
0.45%
Pension Fund
0.14%
Research Firm
0.03%
其他
43.35%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
75
26.89M
39.79%
-8.96M
2025Q2
89
36.69M
54.29%
-200.15K
2025Q1
93
36.63M
54.82%
-389.48K
2024Q4
93
32.50M
49.36%
-965.83K
2024Q3
91
34.60M
52.08%
+657.87K
2024Q2
92
32.44M
48.93%
+1.33M
2024Q1
93
31.91M
48.51%
+375.11K
2023Q4
91
30.61M
46.76%
-676.23K
2023Q3
91
30.34M
46.61%
-4.34M
2023Q2
90
31.34M
48.19%
-3.70M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Alychlo NV
6.99M
10.35%
--
--
Feb 15, 2025
Generation Investment Management LLP
6.79M
10.05%
--
--
Jun 30, 2025
aMoon Fund
5.51M
8.15%
+577.36K
+11.70%
Feb 15, 2025
Akre Capital Management, LLC
3.72M
5.5%
+1.48M
+66.22%
Jun 30, 2025
Balderton Capital (UK) LLP
3.36M
4.97%
--
--
Feb 15, 2025
Camblong (Jurgi)
2.65M
3.93%
+194.16K
+7.89%
Feb 15, 2025
Banque Pictet & Cie S.A.
2.21M
3.27%
-2.76K
-0.12%
Jun 30, 2025
Principal Global Investors (Equity)
1.40M
2.07%
+15.15K
+1.09%
Jun 30, 2025
Millennium Management LLC
584.42K
0.86%
+45.30K
+8.40%
Jun 30, 2025
查看更多

持股ETF

更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
iShares Health Innovation Active ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Health Innovation Active ETF
占比0%
Fidelity Nasdaq Composite Index ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI